Optical contrast agents and imaging systems for detection and diagnosis of cancer

Mark C Pierce1, David J Javier, Rebecca Richards-Kortum

  • 1Department of Bioengineering, Rice University, Houston, TX, USA.

Insights

Optical imaging advances biomedical research and clinical practice by visualizing cellular and tissue changes. This technique uses light interactions and targeted agents for real-time disease visualization, particularly in cancer research.

Area of Science:

  • Biomedical optics
  • Molecular imaging technologies

Background:

  • Molecular imaging is a rapidly growing field with significant potential in biomedical research and clinical applications.
  • Optical imaging leverages the interaction of light with biological tissues for diagnostic and research purposes.

Purpose of the Study:

  • To review fundamental techniques and recent developments in optical molecular imaging.
  • To highlight laboratory and clinical systems for visualizing cancer hallmarks.

Main Methods:

  • Utilizing endogenous optical properties of cells and tissues.
  • Employing molecularly targeted contrast agents for specific labeling.
  • Developing optical imaging systems for real-time visualization.

Main Results:

  • Optical imaging enables quantifiable changes in light properties within cells and tissues.
  • Targeted agents provide unique optical signatures for disease processes.
  • Systems visualize pathophysiology from subcellular to whole organ levels.

Conclusions:

  • Optical molecular imaging offers unique capabilities for biomedical research and clinical practice.
  • The technology facilitates real-time visualization of disease, especially cancer.
  • Continued advancements promise broader applications in diagnostics and therapy.

Related Concept Videos

X-ray Imaging01:24

X-ray Imaging

German physicist Wilhelm Röntgen (1845–1923) was experimenting with electrical current when he discovered that a mysterious and invisible "ray" would pass through his flesh but leave an outline of his bones on a screen coated with a metal compound. In 1895, Röntgen made the first durable record of the internal parts of a living human: an "X-ray" image (as it came to be called) of his wife’s hand. Scientists worldwide quickly began their own experiments with X-rays, and by 1900, X-ray was widely...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies III: Computed Tomography01:27

Imaging Studies III: Computed Tomography

DefinitionComputed Tomography (CT) of the genitourinary (GU) tract is a non-invasive imaging modality that utilizes X-rays and computer processing to generate detailed cross-sectional images of the urinary system, encompassing the kidneys, ureters, bladder, and adjacent structures such as the adrenal glands.PurposeCT scans of the GU tract serve several diagnostic and therapeutic purposes, including:Diagnosis of Urinary Tract Diseases: Detects kidney stones, tumors, cysts, and congenital...